Table E3.
Thirty-day survival and major complications rates of aTAAD surgical repair in patients with preoperative malperfusion syndromes∗ from January 2010 to December 2018 (n = 80)
| Early-career surgeons (n = 40) | Experienced/senior surgeons (n = 40) | P value | Effect size | |
|---|---|---|---|---|
| Major complications† | 27 (67.5) | 23 (57.5) | .489 | 0.103 |
| 30-d survival | 33 (82.5) | 36 (90.0) | .518 | −0.109 |
Data are presented as n (%). Effect sizes are presented as phi coefficient (φ).
Defined as the presence of laboratory or clinical evidence of end-organ ischemia, isolated organ-supplying branch arteries dissection on imaging study not included.
Defined as composite adverse outcomes including re-exploration for bleeding, newly developed dialysis, DSWI, respiratory failure and permanent stroke.